ArticleScientific reports2025
High-performance hexagonal cavity-based plasmonic MIM waveguide biosensor for sensitive and label-free detection of carcinoembryonic antigen (CEA).
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In this research, a plasmonic metal-insulator-metal (MIM) biosensor is proposed and numerically analyzed for label-free and highly sensitive refractive index detection. The design incorporates a hybrid configuration consisting of a hexagonal resonant cavity coupled with a narrow rectangular slit along its lower boundary. This particular arrangement, which has not been previously reported, enables the excitation of two distinct resonance modes that contribute to improved spectral resolution and sensing precision relative to conventional MIM structures. Finite-difference time-domain (FDTD) simulations were employed to investigate the optical response and optimize the geometrical parameters of the device. The optimized sensor demonstrates strong electromagnetic field confinement, achieving a sensitivity of 770.27 nm/RIU and a figure of merit (FoM) of 160.47, both of which surpass values reported in related studies. Owing to its compact geometry and compatibility with nanoimprint lithography, the proposed design can be fabricated with high practicality. These findings suggest that the device offers an efficient and scalable platform for real-time, label-free detection of carcinoembryonic antigen (CEA) and other biomarkers relevant to early-stage disease diagnostics.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.